BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32345379)

  • 21. Bone mineral density utilization in patients with newly diagnosed multiple myeloma.
    Muchtar E; Dagan A; Robenshtok E; Shochat T; Oniashvili N; Amitai I; Raanani P; Magen H
    Hematol Oncol; 2017 Dec; 35(4):703-710. PubMed ID: 27329574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differentiation of Multiple Myeloma and Lytic Bone Metastases: Histogram Analysis.
    Yildirim M; Baykara M
    J Comput Assist Tomogr; 2020; 44(6):953-955. PubMed ID: 32976264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma.
    Zamagni E; Nanni C; Patriarca F; Englaro E; Castellucci P; Geatti O; Tosi P; Tacchetti P; Cangini D; Perrone G; Ceccolini M; Brioli A; Buttignol S; Fanin R; Salizzoni E; Baccarani M; Fanti S; Cavo M
    Haematologica; 2007 Jan; 92(1):50-5. PubMed ID: 17229635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of qualitative and quantitative CT and MRI parameters for monitoring of longitudinal spine involvement in patients with multiple myeloma.
    Horger M; Fritz J; Thaiss WM; Ditt H; Weisel K; Haap M; Kloth C
    Skeletal Radiol; 2018 Mar; 47(3):351-361. PubMed ID: 29222688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recommendations for acquisition, interpretation and reporting of whole body low dose CT in patients with multiple myeloma and other plasma cell disorders: a report of the IMWG Bone Working Group.
    Moulopoulos LA; Koutoulidis V; Hillengass J; Zamagni E; Aquerreta JD; Roche CL; Lentzsch S; Moreau P; Cavo M; Miguel JS; Dimopoulos MA; Rajkumar SV; Durie BGM; Terpos E; Delorme S
    Blood Cancer J; 2018 Oct; 8(10):95. PubMed ID: 30287814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantifying cervical spondylosis: reliability testing of a coherent CT-based scoring system.
    Rydman E; Bankler S; Ponzer S; Järnbert-Pettersson H
    BMC Med Imaging; 2019 May; 19(1):45. PubMed ID: 31146696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multidetector CT of the spine in multiple myeloma: comparison with MR imaging and radiography.
    Mahnken AH; Wildberger JE; Gehbauer G; Schmitz-Rode T; Blaum M; Fabry U; Günther RW
    AJR Am J Roentgenol; 2002 Jun; 178(6):1429-36. PubMed ID: 12034612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic value of whole-body ultra-low dose computed tomography in comparison with spinal magnetic resonance imaging in the assessment of disease in multiple myeloma.
    Ippolito D; Talei Franzesi C; Spiga S; Besostri V; Pezzati S; Rossini F; Sironi S
    Br J Haematol; 2017 May; 177(3):395-403. PubMed ID: 28233900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of QCT Bone Mineral Density and Bone Structure With Vertebral Fractures in Patients With Multiple Myeloma.
    Borggrefe J; Giravent S; Thomsen F; Peña J; Campbell G; Wulff A; Günther A; Heller M; Glüer CC
    J Bone Miner Res; 2015 Jul; 30(7):1329-37. PubMed ID: 25545497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of the CT Syndesmophyte Score (CTSS) in patients with ankylosing spondylitis: data from the SIAS cohort.
    de Bruin F; de Koning A; van den Berg R; Baraliakos X; Braun J; Ramiro S; van Gaalen FA; Reijnierse M; van der Heijde D
    Ann Rheum Dis; 2018 Mar; 77(3):371-377. PubMed ID: 29127093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Recommendations for early identification of damage to the skeleton by malignant processes, and for early diagnosis of multiple myeloma].
    Adam Z; Bednarík J; Neubauer J; Chaloupka R; Fojtík Z; Vanícek J; Pour L; Cermákova Z; Scudla V; Maisnar V; Straub J; Schützová M; Gregora E; Weinreb M; Stuchlíková K; Stanícek J; Hájek R; Krejcí M; Vorlícek J;
    Vnitr Lek; 2006 Nov; 52 Suppl 2():9, 11-31. PubMed ID: 18175427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can whole-body low-dose multidetector CT exclude the presence of myeloma bone disease in patients with monoclonal gammopathy of undetermined significance (MGUS)?
    Spira D; Weisel K; Brodoefel H; Schulze M; Kaufmann S; Horger M
    Acad Radiol; 2012 Jan; 19(1):89-94. PubMed ID: 22142681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of
    Cavo M; Terpos E; Nanni C; Moreau P; Lentzsch S; Zweegman S; Hillengass J; Engelhardt M; Usmani SZ; Vesole DH; San-Miguel J; Kumar SK; Richardson PG; Mikhael JR; da Costa FL; Dimopoulos MA; Zingaretti C; Abildgaard N; Goldschmidt H; Orlowski RZ; Chng WJ; Einsele H; Lonial S; Barlogie B; Anderson KC; Rajkumar SV; Durie BGM; Zamagni E
    Lancet Oncol; 2017 Apr; 18(4):e206-e217. PubMed ID: 28368259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple myeloma seen only on multidetector CT.
    Ehara S
    AJR Am J Roentgenol; 2003 Jan; 180(1):281; author reply 281-2. PubMed ID: 12490521
    [No Abstract]   [Full Text] [Related]  

  • 35. Computed tomography characteristics of multiple myeloma and other osteolytic metastatic bone lesions.
    Mutlu U; Balci A; Özsan GH; Özkal S; Şeyhanli A; Özgül HA
    Acta Radiol; 2021 Dec; 62(12):1639-1647. PubMed ID: 33269940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of Whole-Body DWI and
    Chen J; Li C; Tian Y; Xiao Q; Deng M; Hu H; Wen B; He Y
    AJR Am J Roentgenol; 2019 Sep; 213(3):514-523. PubMed ID: 31166755
    [No Abstract]   [Full Text] [Related]  

  • 37. Multiple Myeloma: Molecular Imaging with 11C-Methionine PET/CT--Initial Experience.
    Dankerl A; Liebisch P; Glatting G; Friesen C; Blumstein NM; Kocot D; Wendl C; Bunjes D; Reske SN
    Radiology; 2007 Feb; 242(2):498-508. PubMed ID: 17179397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can low-dose computed tomographic scan of the spine replace conventional radiography? An evaluation based on imaging myelomas, bone metastases, and fractures from osteoporosis.
    Chassang M; Grimaud A; Cucchi JM; Novellas S; Amoretti N; Chevallier P; Bruneton JN
    Clin Imaging; 2007; 31(4):225-7. PubMed ID: 17599614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Whole body radiography for bone survey screening of cancer and myeloma patients.
    Mulligan M; Smith S; Talmi D
    Cancer Invest; 2008 Nov; 26(9):916-22. PubMed ID: 18608207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of 18F-FDG PET/CT in the assessment of bone involvement in newly diagnosed multiple myeloma: preliminary results.
    Nanni C; Zamagni E; Farsad M; Castellucci P; Tosi P; Cangini D; Salizzoni E; Canini R; Cavo M; Fanti S
    Eur J Nucl Med Mol Imaging; 2006 May; 33(5):525-31. PubMed ID: 16453155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.